July 29, 2025 - 05:02

ALAMEDA, Calif., July 28, 2025--Exelixis, Inc. has announced its financial results for the second quarter of 2025, highlighting significant achievements and advancements in its corporate objectives. The company outlined its ongoing commitment to innovation, detailing progress in both commercial operations and clinical development.
In the second quarter, Exelixis reported robust financial performance, reflecting growth in revenue streams driven by its key product offerings. The company emphasized its strategic focus on enhancing patient access to its therapies, which has been pivotal in driving sales.
Additionally, Exelixis provided insights into its clinical pipeline, showcasing advancements in key studies and potential new indications for existing therapies. The company remains dedicated to expanding its research efforts, with several upcoming milestones set for the remainder of the year.
Overall, Exelixis continues to strengthen its position in the biopharmaceutical landscape, aiming to deliver innovative treatments to patients while achieving sustainable growth.
November 3, 2026 - 05:37
When a Tax Promise Hides the Real BillVoters often hear a simple promise at election time: no new taxes. It sounds reassuring, and it is easy to remember. But when a bond measure appears on the ballot, that promise can hide the true...
November 2, 2026 - 19:17
Centerspace Reports Third Quarter 2026 Financial & Operating ResultsCenterspace (NYSE: CSR) released its financial and operating results for the three and nine months ended September 30, 2026. The report covers key performance indicators including Net Income, Funds...
November 2, 2026 - 04:40
Fiserv (FISV) Q3 earnings: what to expectFinancial technology provider Fiserv is set to release its third quarter earnings results this Tuesday before market hours. Investors will be watching closely for signs of how the company is...
November 1, 2026 - 20:42
Iran Threatens Global Retaliation as Trump Weighs New StrikesOn Saturday, Ayatollah Mojtaba Khamenei warned Iran`s response would be `without any geographical limitations.` The statement signals a sharp escalation in rhetoric as Washington considers another...